Re‐assessing the late <scp>HIV</scp> diagnosis surveillance definition in the era of increased and frequent testing-Reference-Cited by-同舟云学术

Re‐assessing the late HIV diagnosis surveillance definition in the era of increased and frequent testing

Published:2022-09-07 Issue:11 Volume:23 Page:1127-1142
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Medicine

Author:

Kirwan Peter D.¹²^ORCID,Croxford Sara¹^ORCID,Aghaizu Adamma¹^ORCID,Murphy Gary¹^ORCID,Tosswill Jennifer¹,Brown Alison E.¹^ORCID,Delpech Valerie C.¹^ORCID

Affiliation:

1. United Kingdom Health Security Agency London UK

2. Medical Research Council Biostatistics Unit University of Cambridge Cambridge UK

Funder

Medical Research Council Canada

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.13394

Reference49 articles.

1. Reference ranges and sources of variability of CD4 counts in HIV‐seronegative women and men;Maini MK;Genitourin Med,1996

2. Pretreatment CD4 Cell Slope and Progression to AIDS or Death in HIV-Infected Patients Initiating Antiretroviral Therapy—The CASCADE Collaboration: A Collaboration of 23 Cohort Studies

3. Impact of HIV-1 Subtype on CD4 Count at HIV Seroconversion, Rate of Decline, and Viral Load Set Point in European Seroconverter Cohorts

4. Differences in CD4 Cell Counts at Seroconversion and Decline Among 5739 HIV-1–Infected Individuals with Well-Estimated Dates of Seroconversion

5. CD4+T Cell Count Decreases by Ethnicity among Untreated Patients with HIV Infection in South Africa and Switzerland

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of Late HIV Diagnosis and Advanced HIV Disease Among People Living with HIV in Tanzania;HIV/AIDS - Research and Palliative Care;2024-08

2. Impact of national commissioning of pre-exposure prophylaxis (PrEP) on equity of access in England: a PrEP-to-need ratio investigation;Sexually Transmitted Infections;2024-03-20

3. Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: Data from the ICONA cohort;International Journal of Antimicrobial Agents;2024-01

4. Four Decades of HIV: Global Trends, Testing Assays, Treatment, and Challenges;Zoonoses;2024

5. Factors Associated with Late Diagnosis of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) in a University Hospital in Brazil: Challenges to Achieving the 2030 Target;Viruses;2023-10-17